Project Grant K23DK146162
- Federal Grant Award Summary The University of Minnesota received a $759,944 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on March 6, 2026, with a completion date of February 28, 2031. This clinical trial research initiative will investigate a biologically-based approach to obesity prevention in older adolescents and young adults (AYAs) by...
- Federal Grant Award Summary The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 12, 2025, through July 31, 2030. The award supports the Michigan Diabetes Project, a research initiative delivering a virtually administered, evidence-based Peer-Led Diabetes Self-Management Support (PLDSMS)...
- Federal Project Grant Award Summary The Regents of the University of Minnesota received a $308,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective February 1, 2026, with a completion date of December 31, 2028. This pilot clinical trial investigates the efficacy and safety of Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor therapy in islet...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
- Federal Grant Award Summary The University of Minnesota, Office of Sponsored Projects Administration, received a $676,905 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 16, 2026, with completion targeted for January 31, 2031. The research initiative focuses on investigating stromal regulation of pathological bone remodeling in diabetes,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pittsburgh a $343,954 Project Grant on September 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a pilot intervention study addressing health-related social needs (HRSN) in adolescents and young adults with Type 2 Diabetes (T2D). The project, titled ONWARD (Optimizing Navigation for Wellness and...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $4.51 million to the Regents of the University of Minnesota under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on engineered regulatory T cells (Tregs) for Type 1 Diabetes (T1D) treatment. The project, awarded on September 5, 2025, with completion targeted for August 31, 2028, will develop "designer" Tregs...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative, titled "Improving Diabetes Outcomes and Health Disparities by Addressing Unmet Resource Needs," will develop and test adaptive intervention sequences to address...
- Federal Grant Award Summary The University of Michigan received a $780,220 Project Grant award dated February 27, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a clinical optimization trial to evaluate the effectiveness of two scalable digital behavioral intervention components for mitigating Level 2 hypoglycemia (severe low blood glucose)...
- Federal Project Grant Award Summary Dr. Daniel Murphy at the University of Minnesota, Office of Sponsored Projects Administration, received a $166,953 Project Grant award dated July 15, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, which extends through June 30, 2030, supports the development and pilot testing of a pragmatic, cluster-randomized clinical trial...
The University of Minnesota received a $177,877 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through March 31, 2031. This K23 career development award funds the development and evaluation of TEAM-T2D (Technology-Enhanced Adherence to Medication Intervention for Youth With Type 2 Diabetes), a patient-engaged intervention designed to address medication adherence barriers in youth with type 2 diabetes. The research will employ participatory design methods incorporating stakeholder input from youth with type 2 diabetes, parents, and healthcare providers to ensure the intervention's feasibility and acceptability. The grant supports two primary research aims: (1) development and refinement of the TEAM-T2D intervention through patient-engaged participatory research methods, and (2) execution of a pilot randomized controlled trial with 40 youth participants to evaluate feasibility, acceptability, and medication adherence outcomes using validated surveys, qualitative interviews, and electronic adherence monitoring. The award also provides the principal investigator with training in patient-engaged research methods, mixed methodologies, clinical trial design and conduct, and leadership expertise necessary to manage multidisciplinary research initiatives addressing a critical gap in evidence-based adherence interventions for pediatric type 2 diabetes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $177.9k | 3/19/26 |